View in EDS PDF Full Text

Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.
Authors: Li Y; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Thongborisuth T; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Lee R; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Stolberg N; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA., Sweiss N; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.; Discovery Partners Institute, University of Jordan, Amman, Jordan., Lobo-Chan AM; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., Bhat P; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2025 Jun 24, pp. 1-9. Date of Electronic Publication: 2025 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40554787
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Thongborisuth+T%22">Thongborisuth T</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Lee+R%22">Lee R</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Stolberg+N%22">Stolberg N</searchLink>; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Sweiss+N%22">Sweiss N</searchLink>; Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.; Discovery Partners Institute, University of Jordan, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Lobo-Chan+AM%22">Lobo-Chan AM</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Bhat+P%22">Bhat P</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229312169%22">Ocular immunology and inflammation</searchLink> [Ocul Immunol Inflamm] 2025 Jun 24, pp. 1-9. <i>Date of Electronic Publication: </i>2025 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9312169 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-5078 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209273948%22">09273948 </searchLink><i>NLM ISO Abbreviation: </i>Ocul Immunol Inflamm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40554787
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09273948.2025.2504577
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Thongborisuth T
      – PersonEntity:
          Name:
            NameFull: Lee R
      – PersonEntity:
          Name:
            NameFull: Stolberg N
      – PersonEntity:
          Name:
            NameFull: Sweiss N
      – PersonEntity:
          Name:
            NameFull: Lobo-Chan AM
      – PersonEntity:
          Name:
            NameFull: Bhat P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 06
              Text: 2025 Jun 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1744-5078
          Titles:
            – TitleFull: Ocular immunology and inflammation
              Type: main
ResultId 1